NUVA News and Press, NuVasive Inc. From 08/02/23

2023-08-02 20:27:05 ET NuVasive, Inc. (NUVA) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET Company Participants Juliet Cunningham – Vice President-Investor Relations Chris Barry – Chief Executive Officer Matt Harbaugh – Chief Fin...

2023-08-02 16:24:08 ET NuVasive press release ( NASDAQ: NUVA ): Q2 Non-GAAP EPS of $0.56 beats by $0.01 . Revenue of $317.8M (+2.4% Y/Y) misses by $5.32M . For the second quarter of 2023, GAAP and non-GAAP gross profit was $228.3 million, compared to $224.7 mil...

NuVasive Announces Second Quarter 2023 Financial Results PR Newswire – U.S. Cervical continues to deliver greater than 20% year-over-year growth– – International net sales grew 6.8% as reported and 9.8% on a constant currency basis– ...

NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results PR Newswire SAN DIEGO , July 24, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disr...

2023-07-20 15:34:31 ET The deal spread in Globus Medical's ( NYSE: GMED ) planned takeover of Nuvasive ( NASDAQ: NUVA ) widened slightly amid a report that the Federal Trade Commission is evaluating a path toward a potential lawsuit to challenge the deal. The spread widened ...

2023-06-07 03:37:58 ET Summary NuVasive's announced merger with Globus Medical has been approved by shareholders, indicating confidence in the deal. NUVA's exposure to the cervical disc treatment market, which is expected to grow at an 18.5% CAGR into FY'30, could be a key differe...

2023-05-10 22:15:09 ET NuVasive, Inc. (NUVA) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Chris Barry - Chief Executive Officer Matt Harbaugh - Executive Vice President and Ch...

2023-05-10 16:31:46 ET NuVasive press release ( NASDAQ: NUVA ): Q1 Non-GAAP EPS of $0.47 beats by $0.05 . Revenue of $307.7M (+5.8% Y/Y) beats by $9.26M . The Company continues to expect 2023 net sales growth of 6%ꟷ8% on an as reported and constant curre...

NuVasive Announces First Quarter 2023 Financial Results PR Newswire – Continued above-market worldwide net sales growth of 5.8% as reported and 7.7% on a constant currency basis – – U.S. cervical delivers sixth consecutive quarter of greater than 20%...

NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results PR Newswire SAN DIEGO , May 4, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally di...